KLING DOUGLAS F

PrivateCIK: 1699022
Location

BEDMINSTER, NJ

KLING DOUGLAS F (Chief Operating Officer) sold 69.4% of their position (100K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market

Insider sale on the open market — a major position exit. Check remaining position size for full context.

S · 1 sale
InsiderKLING DOUGLAS FCIK 1699022
Officer· Chief Operating Officer
Since Dec 2023
-100K
Net shares
Net seller
$118.9K
Total acquired
1
Open market trades
0B · 1S
5
Total transactions
100K acquired · 200K disposed
Non-Derivative Transactions3

Ordinary Shares

Direct
M · Option Exercise

Shares

+88.11K

Price / share

Trade value

% of position

200.3%
3/17/2025
44K132.11K

Ordinary Shares

Direct
M · Option Exercise

Shares

+11.89K

Price / share

$10.00

Trade value

$118.88K

% of position

9.0%
3/17/2025
132.11K144K

Ordinary Shares

Direct
S · Sale

Shares

100K

Price / share

Trade value

% of position

69.4%
3/17/2025
144K44K
Total

Net shares

+0.00

Net value

$118.88K

Derivative Transactions2

Option (right to buy)

Direct
M · Option Exercise
Converts to

Ordinary Shares

88.11K shares

Shares

88.11K

Strike price

Held after

47.25K

Exercisable

3/17/2025

Option (right to buy)

Direct
M · Option Exercise
Converts to

Ordinary Shares

11.89K shares

Shares

11.89K

Strike price

10

Held after

650.93K

Exercisable

3/17/2025
KLING DOUGLAS F — Insider Transaction (Form 4) Filed Mar 19, 2025 | Finecho